Alessandro Tubita

4PUBLICATIONS
18CO-AUTHORS
Predictive and prognostic markersClinical pharmacology and therapeuticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 27, 2026
Metabolomics Plasma Biomarkers Associated with the HRD Phenotype in Ovarian Cancer.

Alessandro Tubita, Claudia De Angelis, Daniela Grasso

|Sep 13, 2025
Dual-Specificity Protein Phosphatases Targeting Extracellular Signal-Regulated Kinases: Friends or Foes in the Biology of Cancer?

Alessandro Tubita, Dimitri Papini, Ignazia Tusa

|Feb 25, 2025
The MEK5/ERK5 pathway promotes the activation of the Hedgehog/GLI signaling in melanoma cells.

Ignazia Tusa, Sinforosa Gagliardi, Alessio Menconi

|Nov 20, 2021
Inhibition of ERK5 Elicits Cellular Senescence in Melanoma via the Cyclin-Dependent Kinase Inhibitor p21.

Alessandro Tubita, Zoe Lombardi, Ignazia Tusa

Pageof 1